# Safety and Tolerability of ACU-4429

> **NCT00703183** · PHASE1 · COMPLETED · sponsor: **Kubota Vision Inc.** · enrollment: 46 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ACU-4429
- **DRUG:** matching placebo

## Key facts

- **NCT ID:** NCT00703183
- **Lead sponsor:** Kubota Vision Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2012-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00703183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00703183, "Safety and Tolerability of ACU-4429". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00703183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*